Swertiamarin
CAS No. 17388-39-5
Swertiamarin( Swertiamarin | Swertiamaroside )
Catalog No. M12637 CAS No. 17388-39-5
Extracted from Gentianaceae Swertia L. Swertia mussotii Franch.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 108 | In Stock |
|
| 25MG | 253 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSwertiamarin
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Gentianaceae Swertia L. Swertia mussotii Franch.
-
DescriptionExtracted from Gentianaceae Swertia L. Swertia mussotii Franch;Suitability:Methanol,ethanol;Store the product in sealed,cool and dry condition.
-
In Vitro——
-
In Vivo——
-
SynonymsSwertiamarin | Swertiamaroside
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number17388-39-5
-
Formula Weight374.34
-
Molecular FormulaC16H22O10
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C1OCC[C@]2(O)C1=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2C=C
-
Chemical Name(3S,4R,4aR)-4-ethenyl-4a-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4,5,6-tetrahydropyrano[3,4-c]pyran-8-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CRSP-1
Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related peptide (CGRP) and adrenomedullin receptors. Inhibits formation of multinuclear osteoclasts with similar efficacy to CT in vitro. Suppresses food intake and increases body temperature in free-feeding rats, and significantly decreases plasma calcium levels in vivo.
-
Sacituzumab goviteca...
Sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) targeting Trop-2, facilitates the delivery of SN-38. It demonstrates anticancer activity .
-
Physalin O
Physalin O possesses anti-inflammatory activity, it exhibited conjugating abilities with GSH and also showed significant nitric oxide (NO) production inhibiting activities.
Cart
sales@molnova.com